May 9, 2020 / 1:40 AM / 17 days ago

BRIEF-Quidel Receives Emergency Authorization For Rapid Antigen Covid-19 Diagnostic Assay

May 8 (Reuters) - Quidel Corp:

* QUIDEL RECEIVES EMERGENCY AUTHORIZATION FOR RAPID ANTIGEN COVID-19 DIAGNOSTIC ASSAY

* SOFIA® 2 SARS ANTIGEN FIA POINT-OF-CARE TEST OFFERS POSITIVE RESULTS IN 15 MINUTES

* ASSAY IS CURRENTLY AVAILABLE FOR SALE IN UNITED STATES UNDER EUA, AND QUIDEL IS NOW SHIPPING PRODUCT TO ITS CUSTOMERS

* RECEIVED EMERGENCY USE AUTHORIZATION (EUA) FROM U.S. FOOD AND DRUG ADMINISTRATION (FDA) TO MARKET ITS SOFIA® 2 SARS ANTIGEN FIA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below